mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
1e-07 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
0.0002 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0004 |